Ligand Pharmaceuticals Inc (LGND)
Debt Repayment
$822.14M
TTM · Period ending: · USD
LGND Debt Repayment
Latest reported$822.14Mperiod ending
Latest reported$822.14Mperiod ending
LGND TTM Debt Repayment ($8.90M → $822.14M)
TTM debt repayment
High-resolution chart · PNG
LGND debt repayment history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Debt Repayment (USD) |
|---|---|
| 822,140,000 | |
| 338,105,000 | |
| 338,105,000 | |
| 331,813,000 | |
| -30,000 | |
| -27,000 | |
| -25,000 | |
| -64,000 | |
| -68,000 | |
| -76,905,000 | |
| -76,913,000 | |
| -76,720,000 | |
| -114,352,000 | |
| -97,445,000 | |
| -260,801,000 | |
| -251,199,000 | |
| -215,932,000 | |
| -200,557,000 | |
| -146,010,000 | |
| -184,308,000 | |
| -186,019,000 | |
| -142,594,000 | |
| -236,982,000 | |
| -208,434,000 | |
| -231,667,000 | |
| -230,533,000 | |
| -27,323,000 | |
| -223,212,000 | |
| -195,889,000 | |
| -195,889,000 | |
| -195,889,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -2,000 | |
| 242,581,000 | |
| 239,070,000 | |
| 235,634,000 | |
| 232,274,000 | |
| -13,600,000 | |
| -13,308,000 | |
| -19,586,000 | |
| -16,224,000 | |
| -14,433,000 | |
| -11,214,000 | |
| -2,500,000 | |
| -2,500,000 | |
| -1,000,000 | |
| 4,000,000 | |
| 30,000,000 | |
| 30,000,000 | |
| 29,961,000 | |
| 24,919,000 | |
| -91,000 | |
| -172,000 | |
| -227,000 | |
| -320,000 | |
| -3,916,000 | |
| -4,095,000 | |
| -4,357,000 | |
| -4,619,000 | |
| -1,527,000 | |
| -1,811,000 | |
| -2,004,000 | |
| -2,151,000 | |
| -39,919,000 | |
| -14,578,000 | |
| -13,418,000 | |
| -13,510,000 | |
| 24,404,000 | |
| -494,000 | |
| -1,882,000 | |
| -1,539,000 | |
| -1,096,000 | |
| 2,463,000 | |
| 3,870,000 | |
| 4,134,000 | |
| 5,116,000 | |
| 2,079,000 | |
| 814,000 | |
| 73,000 | |
| -1,354,000 | |
| 93,041,000 | |
| 144,519,000 | |
| 95,004,000 | |
| 94,669,000 | |
| 224,000 | |
| -50,791,000 | |
| -1,646,000 | |
| 7,955,000 | |
| 5,203,000 |